Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,188 | -51,834 | -38,571 | -26,574 | -15,323 |
| Accounts payable and accrued liabilities | 140 | -766 | -766 | -562 | -627 |
| Other Working Capital | -3,259 | 2,093 | 552 | 7 | 92 |
| Other Operating Activity | 1,054 | 6,974 | 5,916 | 4,509 | 3,299 |
| Operating Cash Flow | $-13,253 | $-43,533 | $-32,869 | $-22,620 | $-12,559 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 194,997 | -167,038 | -31,889 | -33,897 | -27,099 |
| PPE Investments | -5 | -91 | -60 | -2 | N/A |
| Investing Cash Flow | $194,992 | $-167,129 | $-31,949 | $-33,899 | $-27,099 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37 | 144,721 | 24,324 | N/A | N/A |
| Financing Cash Flow | $37 | $144,721 | $24,324 | $N/A | $0 |
| Beginning Cash Position | 20,688 | 86,629 | 86,629 | 86,629 | 86,629 |
| End Cash Position | 202,464 | 20,688 | 46,135 | 30,110 | 46,971 |
| Net Cash Flow | $181,776 | $-65,941 | $-40,494 | $-56,519 | $-39,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,253 | -43,533 | -32,869 | -22,620 | -12,559 |
| Capital Expenditure | -5 | -91 | -60 | -2 | 0 |
| Free Cash Flow | -13,258 | -43,624 | -32,929 | -22,622 | -12,559 |